GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » EBIT

Biogena Group Invest AG (WBO:BIO) EBIT : €0.18 Mil (TTM As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG EBIT?

Biogena Group Invest AG's earnings before interest and taxes (EBIT) for the six months ended in Jan. 2024 was €0.18 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2024 was €0.18 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Biogena Group Invest AG's annualized ROC % for the quarter that ended in Jan. 2024 was 0.03%. Biogena Group Invest AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Biogena Group Invest AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 2.15%.

Biogena Group Invest AG EBIT Historical Data

The historical data trend for Biogena Group Invest AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG EBIT Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
EBIT
0.15 0.82 0.30 0.18

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
EBIT 0.15 0.82 0.30 0.18

Competitive Comparison of Biogena Group Invest AG's EBIT

For the Packaged Foods subindustry, Biogena Group Invest AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biogena Group Invest AG's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's EV-to-EBIT falls into.


Biogena Group Invest AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was €0.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogena Group Invest AG  (WBO:BIO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Biogena Group Invest AG's annualized ROC % for the quarter that ended in Jan. 2024 is calculated as:

ROC % (Q: Jan. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2023 ) + Invested Capital (Q: Jan. 2024 ))/ count )
=0.003 * ( 1 - 1.7% )/( (8.576 + 8.485)/ 2 )
=0.002949/8.5305
=0.03 %

where

Invested Capital(Q: Jan. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8.699 - 0.099 - ( 0.024 - max(0, 0.103 - 1.183+0.024))
=8.576

Invested Capital(Q: Jan. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8.859 - 0.351 - ( 0.023 - max(0, 0.355 - 1.343+0.023))
=8.485

Note: The Operating Income data used here is one times the annual (Jan. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Biogena Group Invest AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jan. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jan. 2023  Q: Jan. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0.176/( ( (0 + max(-0.046, 0)) + (0 + max(-0.308, 0)) )/ 2 )
=0.176/( ( 0 + 0 )/ 2 )
=0.176/0
= %

where Working Capital is:

Working Capital(Q: Jan. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.036 + 0 + 0.021) - (0.099 + 0 + 0.004)
=-0.046

Working Capital(Q: Jan. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.004 + 0 + 0.043) - (0.351 + 0 + 0.004)
=-0.308

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Jan. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Biogena Group Invest AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jan. 2024 )
=0.176/8.196
=2.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogena Group Invest AG EBIT Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogena Group Invest AG (WBO:BIO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » EBIT
Comparable Companies
WBO:STM XSWX:NESN KHC XPAR:BN GIS SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF BIMBOA HRL K MKC SGX:F34 SAU:2280 DUB:KRZ XAMS:JDEP LW
Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Website
https://www.biogenagroup.com
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.